ProQR Therapeutics Creating RNA therapies for patients in need

Decorative image

ProQR Community News

  • “A new way of designing medicines”

    Community news

    The potential of this new technology for RNA therapeutics is immense, says Bart Klein, who was at the forefront of the Axiomer® technology development. ProQR’s Sr. Vice President Innovation makes his point about the promise of Axiomer® technology: “This opens up a whole new way of designing medicines for genetic diseases that were previously ‘out of reach’ for existing technologies.”

    A photo of Bart Klein
  • Exploring why companies partner their technology

    Community news

    Partnerships in our industry are very common as companies look to benefit from knowledge and resource sharing. In this blog we explore why companies, like ProQR, partner with other companies.

    Lenka in the Lab